3,110
Views
2
CrossRef citations to date
0
Altmetric
Coronavirus – Research Paper

Knowledge, perception, and acceptance toward the booster dose of COVID-19 vaccine among patients visiting dental clinics in Aseer region of KSA

, , , , , , , , & show all
Article: 2095162 | Received 18 Mar 2022, Accepted 19 Jun 2022, Published online: 20 Jul 2022

References

  • World Health Organization. Coronavirus disease (COVID-19). Situation Report-130. World Health Organization; 2020 May 29 [accessed Nov 30]. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200529-covid-19-sitrep-130.pdf?sfvrsn=bf7e7f0c_4.
  • World Health Organization. DRAFT landscape of COVID-19 candidate vaccines. World Health Organization; 2020 June 24 [accessed Nov 30]. https://www.who.int/who-documents-detail/draft-landscapeof-covid-19-candidate-vaccines.
  • Sanger DE, Kirkpatrick DD, Zimmer C, Thomas K, Wee SL. Profits and pride at stake, the race for a vaccine intensifies. The New York Times. 2020 May 2 [accessed Nov 30]. https://www.nytimes.com/2020/05/02/us/politics/vaccines-coronavirus-research.html.
  • Corbett KS, Gagne M, Wagner DA, O’Connell S, Narpala SR, Flebbe DR, Andrew SF, Davis RL, Flynn B, Johnston TS, et al. Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates. Science. 2021;374(6573):1–8. Epub 2021 Oct 21. PMID: 34672695. doi:10.1126/science.abl8912.
  • Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, Gower C, Kall M, Groves N, O’Connell AM, et al. Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl J Med. 2022;386(16):1532–1546. Epub 2022 Mar 2. PMID: 35249272. doi:10.1056/NEJMoa2119451.
  • World Health Organization. World Health Organization outbreak communication planning guide. Geneva, Switzerland: WHO; 2008 [accessed Nov 30]. http://refhub.elsevier.com/S0277-9536(20)30575-X/sref49.
  • Funke D. Rush Limbaugh is spreading a conspiracy theory about the Coronavirus and Trump’s re-election. Washington (DC): Poynter Institute; 2020 [accessed Nov 30]. http://refhub.elsevier.com/S0277-9536(20)30575-X/sref13.
  • Infotagion. Factcheck: is COVID-19 a “Big Pharma” Conspiracy? 2020 [accessed Nov 30]. http://refhub.elsevier.com/S0277-9536(20)30575-X/sref22.
  • Lee BY. No, COVID-19 was not bioengineered. Here’s the research that Debunks that idea. Forbes. 2020 [accessed Nov 30]. http://refhub.elsevier.com/S0277-9536(20)30575-X/sref28.
  • Lewandowsky S, Ecker UKH, Seifert CM, Schwarz N, Cook J. Misinformation and its correction: continued influence and successful debiasing. Psychol Sci Public Interest. 2012;13(3):106–131. PMID: 26173286. doi:10.1177/1529100612451018.
  • Uscinski JE, Klofstad C, Atkinson MD. What drives conspiratorial beliefs? the role of informational cues and predispositions. Political Res Q. 2016;69:57–71. doi:10.1177/1065912915621621.
  • Douglas KM, Uscinski JE, Sutton RM, Cichocka A, Nefes T, Ang CS, Deravi F. Understanding conspiracy theories. Polit Psychol. 2019;40:3–35. doi:10.1111/pops.12568.
  • Hornsey MJ, Finlayson M, Chatwood G, Begeny CT. Donald Trump and vaccination: the effect of political identity, conspiracist ideation and presidential tweets on vaccine hesitancy. J Exp Soc Psychol. 2020;88:103947. doi:10.1060/j.jesp.2019.103947.
  • Jolley DD, Douglas KM. The effects of anti-vaccine conspiracy theories on vaccination intentions. PloS One. 2014;9(2):389177. PMID: 24586574. doi:10.1371/journal.pone.0089177.
  • Greenwood B. The contribution of vaccination to global health: past, present and future. Philos Trans R Soc B. 2014;369(1645):20130433. PMID: 24821919. doi:https://doi.org/10.1098/rstb.2013.0433.
  • Daniel RD, Jamieson KH. Conspiracy theories as barriers to controlling the spread of COVID-19 in the U.S. Soc Sci Med. 2020;263:113356. PMID: 32967786. doi:10.1016/j.socscimed.2020.113356.
  • Glanz K, Rimer BK, Viswanath K. Health behavior and health education: theory, research, and practice. 4th ed. San Fracisco: John Wiley & Sons; 2008.
  • Becker MH, Maiman LA, Kirscht JP, Haefner DP, Drachman RH. The health belief model and predic- tion of dietary compliance: a field experiment. J Health Soc Behav. 1977;18(4):348–366. PMID: 617639. doi:10.2307/2955344.
  • Lucia VC, Kelekar A, Afonso NM. COVID-19 vaccine hesitancy among medical students. J Public Health (Oxf). 2021;43:445–449. PMID: 33367857. doi:10.1093/pubmed/fdaa230.
  • Yang R, Penders B, Horstman K. Addressing vaccine hesitancy in China: a Scoping Review of Chinese Scholarship. Vaccines. 2019;8(1):2. PMID: 31861816. doi:10.3390/vaccines8010002.
  • Tarawneh O, Tarawneh H. Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine. Am J Hematol. 2021;96(5):E133–E134. PMID: 33476455. doi:10.1002/ajh.26106.
  • Garvey LH, Nasser S. Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit? COVID-19 CORRESPONDENCE. Br J Anaesth. 2021;126(3):e106–e108. PMID: 33386124. doi:10.1016/j.bja.2020.12.020.
  • Widge AT, Rouphael NG, Jackson LA, Anderson EJ, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, et al. Durability of responses after SARS-CoV-2 mRNA-1273 vaccination. N Engl J Med. 2021;384(1):80–82. PMID: 3327038. doi:10.1056/NEJMc2032195.
  • Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, et al. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med. 2020;383:2427–2438. PMID: 32991794. doi:10.1056/NEJMoa2028436.
  • Shrotri M, Navaratnam AM, Nguyen V, Byrne T, Geismar C, Fragaszy E, Beale S, Fong WLE, Patel P, Kovar J, et al. Spike-Antibody waning after second dose of BNT162b2 or ChAdox1. Lancet. 2021;398(10298):385–387. PMID: 34274038. doi:10.1016/S0140-6736(21)01642-1.
  • Mizrahi B, Lotan R, Kalkstein N, Peretz A, Perez G, Ben-Tov A, Chodick G, Gazit S, Patalon T. Correlation of SARS-CoV-2 breakthrough infections to time-from-vaccine. Nat Commun. 2021;12(1):6379. PMID: 34737312. doi:10.1038/s41467-021-26672-3.
  • Shekhar R, Garg I, Pal S, Kottewar S, Sheikh AB. COVID-19 vaccine booster: to boost or not to boost. Infect Dis Rep. 2021;13:924–929. PMID: 34842753; PMCID: PMC8628913. doi:10.3390/idr13040084.
  • Arora S, Abullais SS, Attar N, Pimpale S, Saifullah ZK, Saluja P, Abdulla AM, Shamsuddin S. Evaluation of knowledge and preparedness among Indian dentists during the current COVID-19 pandemic: a cross-sectional study. J Multidiscip Healthc. 2020;13:841–854. PMID: 32922024. doi:10.2147/JMDH.S268891.
  • Hemmer CJ, Löbermann M, Reisinger EC. COVID-19: epidemiology and mutations: an update. Radiologe. 2021;61(10):880–887. PMID: 34542699. doi:10.1007/s00117-021-00909-0.
  • Blanco JR, Cobos-Ceballos MJ, Navarro F, Sanjoaquin I, Arnaiz de Las Revillas F, Bernal E, Buzon-Martin L, Viribay M, Romero L, Espejo-Perez S, et al. Pulmonary long-term consequences of COVID-19 infections after hospital discharge. Clin Microbiol Infect. 2021;27:892–896. PMID: 33662544. doi:10.1016/j.cmi.2021.02.019.
  • Ioannou P, Karakonstantis S, Astrinaki E, Saplamidou S, Vitsaxaki E, Hamilos G, Sourvinos G, Kofteridis DP. Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers. Infect Dis (Lond). 2021;53(11):876–879. PMID: 34176397. doi:10.1080/23744235.2021.1945139.
  • Shi JC, Yu ZJ, He GQ, Chen W, Ye XC, Wu ZX, Zhu XQ, Pan JZ, Jiang XG. Epidemiological features of 105 patients infected with the COVID-19. J Natl Med Assoc. 2021;113:212–217. PMID: 33268103. doi:10.1016/j.jnma.2020.09.151.
  • Center for Disease Control and Prevention. SARS-CoV-2 variant classifications and definitions. 2021 Nov 30 [accessed Dec 30]. https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html.
  • Center for Disease Control and Prevention. COVID-19 vaccine booster shots. 2021 Nov 30 [accessed Dec 30]. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html.
  • EMA Pandemic Task Force for COVID-19. Heterologous primary and booster COVID-19 vaccination evidence based regulatory considerations. 2021 Dec 13 [accessed Dec 30]. https://www.ema.europa.eu/en/documents/report/heterologous-primary-booster-covid-19-vaccination-evidence-based-regulatory-considerations_en.pdf.
  • Alduwayghiri EM, Khan N. Acceptance and attitude toward COVID-19 vaccination among the public in Saudi Arabia: a cross-sectional study. J Contemp Dent Pract. 2021;22:730–734. PMID: 34615775. doi:10.5005/jp-journals-10024-3114.
  • Yadete T, Batra K, Netski DM, Antonio S, Patros MJ, Bester JC. Assessing acceptability of COVID-19 vaccine booster dose among adult Americans: a cross-sectional study. Vaccines (Basel). 2021;9(12):1424. PMID: 3496017. doi:10.3390/vaccines9121424.
  • Lai X, Zhu H, Wang J, Huang Y, Jing R, Lyu Y, Zhang H, Feng H, Guo J, Fang H. Public perceptions and acceptance of COVID-19 booster vaccination in China: a cross-sectional study. Vaccines (Basel). 2021;9(12):1461. PMID: 34960208. doi:10.3390/vaccines9121461.
  • Toro-Ascuy D, Cifuentes-Muñoz N, Avaria A, Pereira-Montecinos C, Cruzat G, Zorondo-Rodriguez F, Fuenzalida LF. Underlying factors that influence the acceptance of COVID-19 vaccine in a country with a high vaccination rate. Vaccines (Basel). 2022;10:681. PMID: 35632437. doi:10.3390/vaccines10050681.